TOURMALINE BIO, INC. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c1ecc236-104e-4890-9580-e5a3d9ac143d/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-73.2M | 2024-01-01 – 2024-12-31 | evidence 0001827506-25-000027 |
| FY 2023 | $-42.1M | 2023-01-01 – 2023-12-31 | evidence 0001827506-24-000015 |
| FY 2022 | $-19.7M | 2022-01-01 – 2022-12-31 | evidence 0001827506-24-000015 |
| FY 2021 | $-47.8M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-009714 |
| FY 2020 | $-22.7M | 2020-01-01 – 2020-12-31 | evidence 0000950170-22-004105 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).